HeadlinesBriefing favicon HeadlinesBriefing.com

WHO Chief Slams US mRNA Research Cuts

Bloomberg Markets •
×

World Health Organization Director-General Tedros Adhanom Ghebreyesus has criticized the US decision to halt funding for mRNA technology research. In an interview with Mishal Husain, Tedros stated that defunding this research represents a wrong decision that could have serious implications for global health innovation. The WHO chief emphasized the importance of continuing to develop this technology.

mRNA research gained prominence during the Covid-19 pandemic when it enabled the rapid development of highly effective vaccines by companies like Pfizer-BioNTech and Moderna. These vaccines demonstrated the potential of mRNA technology to address not just infectious diseases but potentially cancer and other conditions. Tedros's comments highlight growing concerns about the US government's approach to funding scientific research.

The funding cuts come amid broader debates about research priorities and budget allocations. Health experts warn that halting mRNA research could slow progress on future vaccines and treatments. Tedros's criticism adds to mounting pressure on US policymakers to reconsider the funding decision, particularly given the technology's proven track record during the global health crisis.